OBJECTIVES: The aim of this study was a large scale investigation of myositis-associated circulating miRNA molecules and also determination of expression of these candidate molecules in relation to clinical activity of myositis. METHODS: RNA, containing also miRNAs, was isolated from sera of 28 patients suffering from idiopathic inflammatory myopathies (IIM) and 16 healthy controls. Expression of miRNAs was determined using a miRNA microarray method. Statistical analysis of miRNA expression was carried out using Arraystar software. RESULTS: Our results showed 23 significantly differentially expressed miRNAs. Six miRNAs were differentially expressed in IIM compared to healthy controls. In dermatomyositis (DM) we found 3 and in polymyositis (PM) 6 differentially expressed miRNAs compared to controls. Three miRNAs were up-regulated in patients with highly active disease compared to patients with low disease activity. Furthermore, we found 26 significantly differentially expressed miRNAs in SLE patients compared to IIM, DM and PM patients. CONCLUSIONS: This is the first study that comprehensively describes expression levels of circulating miRNAs in serum of patients suffering from IIM. It can be expected that some of these deregulated miRNA molecules are involved in aetiology of IIM and may potentially serve as molecular markers for IIM development or for monitoring of disease activity.

Department of Developmental Biochemistry University Medical Center Göttingen Göttingen Germany

Department of Experimental and Clinical Rheumatology Institute of Rheumatology Prague Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc16020140

003      

CZ-PrNML

005      

20170504155806.0

007      

ta

008      

160722s2015 it f 000 0|eng||

009      

AR

035    __

$a (PubMed)26574749

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a it

100    1_

$a Mišunová, Martina $u Department of Experimental and Clinical Rheumatology, Institute of Rheumatology, Prague, Czech Republic. remakova@revma.cz. $7 xx0165670

245    10

$a Microarray analysis of circulating micro RNAs in the serum of patients with polymyositis and dermatomyositis reveals a distinct disease expression profile and is associated with disease activity / $c M. Misunova, G. Salinas-Riester, S. Luthin, C. Pommerenke, M. Husakova, J. Zavada, M. Klein, L. Plestilova, T. Svitalkova, P. Cepek, P. Novota, J. Vencovsky,

520    9_

$a OBJECTIVES: The aim of this study was a large scale investigation of myositis-associated circulating miRNA molecules and also determination of expression of these candidate molecules in relation to clinical activity of myositis. METHODS: RNA, containing also miRNAs, was isolated from sera of 28 patients suffering from idiopathic inflammatory myopathies (IIM) and 16 healthy controls. Expression of miRNAs was determined using a miRNA microarray method. Statistical analysis of miRNA expression was carried out using Arraystar software. RESULTS: Our results showed 23 significantly differentially expressed miRNAs. Six miRNAs were differentially expressed in IIM compared to healthy controls. In dermatomyositis (DM) we found 3 and in polymyositis (PM) 6 differentially expressed miRNAs compared to controls. Three miRNAs were up-regulated in patients with highly active disease compared to patients with low disease activity. Furthermore, we found 26 significantly differentially expressed miRNAs in SLE patients compared to IIM, DM and PM patients. CONCLUSIONS: This is the first study that comprehensively describes expression levels of circulating miRNAs in serum of patients suffering from IIM. It can be expected that some of these deregulated miRNA molecules are involved in aetiology of IIM and may potentially serve as molecular markers for IIM development or for monitoring of disease activity.

650    _2

$a dospělí $7 D000328

650    _2

$a studie případů a kontrol $7 D016022

650    _2

$a dermatomyozitida $x krev $x genetika $7 D003882

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a stanovení celkové genové exprese $x metody $7 D020869

650    _2

$a regulace genové exprese $7 D005786

650    _2

$a genetické markery $7 D005819

650    _2

$a genetická predispozice k nemoci $7 D020022

650    _2

$a lidé $7 D006801

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a mikro RNA $x krev $x genetika $7 D035683

650    _2

$a lidé středního věku $7 D008875

650    12

$a sekvenční analýza hybridizací s uspořádaným souborem oligonukleotidů $7 D020411

650    _2

$a fenotyp $7 D010641

650    _2

$a prediktivní hodnota testů $7 D011237

650    _2

$a stupeň závažnosti nemoci $7 D012720

650    _2

$a software $7 D012984

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Salinas-Riester, Gabriela $u Department of Developmental Biochemistry, University Medical Center Göttingen, Göttingen, Germany.

700    1_

$a Luthin, Susanne $u Department of Developmental Biochemistry, University Medical Center Göttingen, Göttingen, Germany.

700    1_

$a Pommerenke, Claudia $u Department of Developmental Biochemistry, University Medical Center Göttingen, Göttingen, Germany.

700    1_

$a Hušáková, Markéta, $u Department of Experimental and Clinical Rheumatology, Institute of Rheumatology, Prague, Czech Republic. $d 1977- $7 xx0143346

700    1_

$a Závada, Jakub $u Department of Experimental and Clinical Rheumatology, Institute of Rheumatology, Prague, Czech Republic. $7 xx0160054

700    1_

$a Klein, Martin $u Department of Experimental and Clinical Rheumatology, Institute of Rheumatology, Prague, Czech Republic. $7 xx0092749

700    1_

$a Pleštilová, Lenka $u Department of Experimental and Clinical Rheumatology, Institute of Rheumatology, Prague, Czech Republic. $7 xx0160053

700    1_

$a Svitálková, Táňa $u Department of Experimental and Clinical Rheumatology, Institute of Rheumatology, Prague, Czech Republic. $7 xx0200433

700    1_

$a Cepek, Pavel $u Department of Experimental and Clinical Rheumatology, Institute of Rheumatology, Prague, Czech Republic.

700    1_

$a Novota, Peter $u Department of Experimental and Clinical Rheumatology, Institute of Rheumatology, Prague, Czech Republic. $7 xx0061182

700    1_

$a Vencovský, Jiří, $u Department of Experimental and Clinical Rheumatology, Institute of Rheumatology, Prague, Czech Republic. $d 1953- $7 jo20000080529

773    0_

$w MED00001116 $t Clinical and experimental rheumatology $x 0392-856X $g Roč. 34, č. 1 (2015), s. 17-24

856    41

$u https://pubmed.ncbi.nlm.nih.gov/26574749 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20160722 $b ABA008

991    __

$a 20170504160135 $b ABA008

999    __

$a ok $b bmc $g 1154810 $s 944668

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2015 $b 34 $c 1 $d 17-24 $e 20151117 $i 0392-856X $m Clinical and Experimental Rheumatology $n Clin Exp Rheumatol $x MED00001116

GRA    __

$a NT12452 $p MZ0

LZP    __

$a Pubmed-20160722